Varex Imaging Corporation (VREX) Stock Analysis

Company Overview

Varex Imaging Corporation (VREX) is capitalised at $780.16M on the latest close. The company sits in the Healthcare sector, in the Medical Devices industry. The company reports 2,500 employees.

The 52-week range on file runs from $9.09 to $18.63. The most recent close on file for VREX is $18.51, dated September 4, 2026. That is −$0.01 (−0.05%) against the previous close. The latest close sits 103.63% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $844.60M. Against the prior fiscal year total of $811.00M, that is a change of +4.14%. The same year closed with a net loss of $70.30M. The reported profit margin is 2.56%. That is 4.2 percentage points above the Medical Devices median of −1.69%. Earnings per share on a trailing basis come to 0.53.

Across the 4 fiscal years on file, revenue moves from $859.40M in 2022 to $844.60M in 2025. Of those 4 years, 2 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 34.92. That is 30.3% above the Medical Devices median of 26.8. On forward earnings the ratio is 17.59. The PEG ratio, which sets the P/E against expected earnings growth, reads 4.98. Measured against sales, the shares trade at 0.9 times revenue. On price-to-sales that is 0.3 times the Medical Devices median of 2.98. 151 Medical Devices companies report these metrics, and the medians quoted come from that group.

The trailing one-year price return is +58.75%. Across 5 years the annualized return works out at −8.78%. Beta against the wider market is reported at 0.96. Annualized volatility over the trailing 9 years is 48.86%.

Growth & Income

The record shows no dividend for VREX.

So far in 2026 the price is +58.88%. Across the complete calendar years on file, 2021 returned +89.15% and 2020 returned −44.05%. Of the 9 complete calendar years on file, 4 finished higher.